- Home
- GCV vs LNSR Comparison
GCV vs LNSR Comparison
Compare GCV & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCV
- LNSR
- Stock Information
- Founded
- GCV 1988
- LNSR 2004
- Country
- GCV United States
- LNSR United States
- Employees
- GCV N/A
- LNSR N/A
- Industry
- GCV Finance/Investors Services
- LNSR Medical Electronics
- Sector
- GCV Finance
- LNSR Health Care
- Exchange
- GCV Nasdaq
- LNSR Nasdaq
- Market Cap
- GCV 76.3M
- LNSR 63.4M
- IPO Year
- GCV N/A
- LNSR N/A
- Fundamental
- Price
- GCV $3.89
- LNSR $7.70
- Analyst Decision
- GCV
- LNSR
- Analyst Count
- GCV 0
- LNSR 0
- Target Price
- GCV N/A
- LNSR N/A
- AVG Volume (30 Days)
- GCV 57.9K
- LNSR 43.0K
- Earning Date
- GCV 01-01-0001
- LNSR 11-07-2024
- Dividend Yield
- GCV 13.04%
- LNSR N/A
- EPS Growth
- GCV N/A
- LNSR N/A
- EPS
- GCV N/A
- LNSR N/A
- Revenue
- GCV N/A
- LNSR $48,868,000.00
- Revenue This Year
- GCV N/A
- LNSR $25.07
- Revenue Next Year
- GCV N/A
- LNSR $24.95
- P/E Ratio
- GCV N/A
- LNSR N/A
- Revenue Growth
- GCV N/A
- LNSR 21.29
- 52 Week Low
- GCV $3.15
- LNSR $2.67
- 52 Week High
- GCV $4.58
- LNSR $8.17
- Technical
- Relative Strength Index (RSI)
- GCV 47.06
- LNSR 57.25
- Support Level
- GCV $3.74
- LNSR $7.33
- Resistance Level
- GCV $4.14
- LNSR $7.98
- Average True Range (ATR)
- GCV 0.09
- LNSR 0.51
- MACD
- GCV -0.03
- LNSR -0.07
- Stochastic Oscillator
- GCV 37.50
- LNSR 63.33
About GCV Gabelli Convertible and Income Securities Fund Inc. (The)
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC is a diversified closed-end management investment company. Its investment objective is to seek a high level of total return through a combination of current income and capital appreciation by investing in convertible securities. The company invests in various portfolios such as Health Care, Financial Services, Real Estate Investment Trust, Energy and Utilities, Telecommunications, Food and Beverage, Aerospace and Automotive and others. All the operation of the group is operated through the regions of United States.
About LNSR LENSAR Inc.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit.